Healthcare Sector

MRKR

Market Tracker

$1.57
-0.06
(-3.68%)
8:00 pm
Next Earnings: (est.) 08/12/23 12:00 am
  • MRKR (Selected)

    Marker Therapeutics, Inc.

MRKR Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRKR Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRKR Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRKR Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRKR Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRKR Major Holders

Name Pct Held Shares Total
Vanguard Extended Market Index Fund 0.99% 87.14k 418.26k
Vanguard Total Stock Market Index Fund 0.86% 75.95k 364.56k
Fidelity Extended Market Index Fund 0.43% 37.57k 180.33k
iShares Core S&P Total U.S. Stock Market ETF 0.12% 10.6k 50.87k
Fidelity Total Market Index Fund 0.10% 8.95k 42.96k
Vanguard Institutional Index-Inst Total Stock Market Ind 0.06% 5.69k 27.31k
Fidelity Series Total Market Index Fund 0.06% 5.6k 26.9k
Vanguard Balanced Index Fund 0.06% 5.5k 26.38k
Fidelity NASDAQ Composite Index Fund 0.03% 2.34k 11.24k
USAA Mutual Fd Tr-Extended Market Index Fd 0.01% 645 3.1k

MRKR News

  • Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit

    11/26 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

    05/15 04:15 pm

    GlobeNewswire Inc.

    Read more
  • Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies 

    04/08 07:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

    03/25 05:45 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

    03/22 12:30 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

    01/22 08:30 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization

    01/08 09:24 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

    12/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

    11/09 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    09/11 01:38 pm

    Benzinga

    Read more
  • Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse

    09/11 07:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

    08/30 08:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

    08/14 04:30 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Non-Clinical Proof-of-Concept Data and Update on Clinical Readiness for the MT-401 Off-the-Shelf Program

    08/07 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session

    07/31 03:30 pm

    Benzinga

    Read more
  • Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    07/24 02:54 pm

    Benzinga

    Read more
  • Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    07/10 12:34 pm

    Benzinga

    Read more
  • European Medicines Agency Grants Orphan Drug Designation for MT-401 developed by Marker Therapeutics for the Treatment of AML Patients

    07/10 07:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports MT-401 Non-Clinical Data in AML Cells after Hypomethylating Agent Administration

    06/26 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    06/13 12:47 pm

    Benzinga

    Read more
  • Nasdaq Gains 1%; US Budget Deficit Widens In May

    06/12 02:54 pm

    Benzinga

    Read more
  • Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    06/12 01:03 pm

    Benzinga

    Read more
  • Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike Higher

    06/12 12:05 pm

    Benzinga

    Read more
  • Marker Therapeutics Announces First Lymphoma Patient Treated with MT-601 in Phase 1 Clinical Trial

    06/12 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    06/09 12:49 pm

    Benzinga

    Read more
  • Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket

    06/05 08:10 am

    Benzinga

    Read more
  • Utilizing Fundamental Analysis for Your Penny Stocks? 3 Tips 

    06/01 06:00 am

    PennyStocks

    Read more
  • Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results

    05/31 02:39 pm

    Benzinga

    Read more
  • Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    05/31 01:01 pm

    Benzinga

    Read more
  • Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views

    05/31 12:06 pm

    Benzinga

    Read more
  • Marker Therapeutics Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells

    05/31 06:30 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Appoints Monic Stuart, M.D., as Chief Medical Officer

    05/08 07:30 am

    GlobeNewswire Inc.

    Read more
  • 7 Low Float Penny Stocks To Watch After SNTG Stock Explodes

    05/01 12:10 pm

    PennyStocks

    Read more
  • Marker Therapeutics Announces Comprehensive Non-Dilutive Agreement With CellReady™

    05/01 07:30 am

    GlobeNewswire Inc.

    Read more
  • Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    04/17 01:27 pm

    Benzinga

    Read more
  • Marker Therapeutics Reports Fiscal Year 2022 Corporate and Financial Results

    03/22 08:10 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million

    12/13 08:00 am

    GlobeNewswire Inc.

    Read more
  • Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session

    11/16 03:02 pm

    Benzinga

    Read more
  • MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Tops Revenue Estimates

    11/10 06:35 pm

    Zacks Investment Research

    Read more
  • Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday

    10/18 05:27 am

    Benzinga

    Read more
  • Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session

    10/17 12:23 pm

    Benzinga

    Read more
  • Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday

    10/17 05:21 am

    Benzinga

    Read more
  • 3 Hot Penny Stocks To Buy For Under $1 Right Now

    10/14 12:53 pm

    PennyStocks

    Read more
  • Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday

    09/30 04:49 am

    Benzinga

    Read more
  • Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday's Mid-Day Session

    09/29 12:45 pm

    Benzinga

    Read more
  • Marker Therapeutics Awarded $2 Million Grant from U.S. FDA to Support Marker’s Phase 2 ARTEMIS Trial of MT-401 in Post-Transplant AML

    09/13 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday

    09/09 04:13 am

    Benzinga

    Read more
  • Marker Therapeutics to Participate in Cantor Fitzgerald Cell and Genetic Medicines Conference

    09/08 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket

    08/22 07:13 am

    Benzinga

    Read more
  • Marker Therapeutics Reports Q2 2022 Operating and Financial Results

    08/11 04:22 pm

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: